Iowa Attorney General Brenna Bird has filed a sweeping lawsuit against major insulin manufacturers and pharmacy benefit managers (PBMs), alleging a coordinated, years-long scheme to artificially inflate the prices of insulin and other...
Iowa Attorney General Brenna Bird has filed a sweeping lawsuit against major insulin manufacturers and pharmacy benefit managers (PBMs), alleging a coordinated, years-long scheme to artificially inflate the prices of insulin and other...
California’s most ambitious pharmacy benefit manager (PBM) reform effort has drawn an immediate legal challenge, as the Pharmaceutical Care Management Association (PCMA) filed a federal lawsuit contesting key provisions of Senate Bill 41 (SB...
California’s most ambitious pharmacy benefit manager (PBM) reform effort has drawn an immediate legal challenge, as the Pharmaceutical Care Management Association (PCMA) filed a federal lawsuit contesting key provisions of Senate Bill 41 (SB...
An Arizona-based compounding pharmacy has filed an antitrust lawsuit accusing Eli Lilly and Novo Nordisk of unlawfully restricting competition in the market for GLP-1 medications, escalating a legal battle over compounded versions of...
An Arizona-based compounding pharmacy has filed an antitrust lawsuit accusing Eli Lilly and Novo Nordisk of unlawfully restricting competition in the market for GLP-1 medications, escalating a legal battle over compounded versions of...
Oregon Attorney General Dan Rayfield has filed a sweeping lawsuit against 3 of the nation’s largest insulin manufacturers and 3 major pharmacy benefit managers (PBMs), alleging a coordinated scheme to artificially inflate insulin prices at...
Oregon Attorney General Dan Rayfield has filed a sweeping lawsuit against 3 of the nation’s largest insulin manufacturers and 3 major pharmacy benefit managers (PBMs), alleging a coordinated scheme to artificially inflate insulin prices at...
A major nonprofit health system has filed a federal lawsuit accusing leading insulin manufacturers and pharmacy benefit managers (PBMs) of conspiring to inflate insulin prices through rebate-driven pricing practices that allegedly harm...
A major nonprofit health system has filed a federal lawsuit accusing leading insulin manufacturers and pharmacy benefit managers (PBMs) of conspiring to inflate insulin prices through rebate-driven pricing practices that allegedly harm...
West Virginia has sued Optum, alleging the PBM’s rebate-driven formulary practices, manufacturer collaborations, data sharing, mail-order dispensing, and discount card programs contributed to the state’s opioid crisis. The lawsuit seeks...
West Virginia has sued Optum, alleging the PBM’s rebate-driven formulary practices, manufacturer collaborations, data sharing, mail-order dispensing, and discount card programs contributed to the state’s opioid crisis. The lawsuit seeks...
The US Attorney’s Office for the Southern District of New York has announced a $37.76 million settlement with CVS Pharmacy, Inc. to resolve allegations that the company violated the False Claims Act by over-dispensing insulin pens and...
The US Attorney’s Office for the Southern District of New York has announced a $37.76 million settlement with CVS Pharmacy, Inc. to resolve allegations that the company violated the False Claims Act by over-dispensing insulin pens and...
The Federal Trade Commission’s enforcement action against Caremark Rx, LLC, Zinc Health Services, LLC, and related entities—which centers on how pharmacy benefit managers (PBMs) and their affiliated group purchasing organizations (GPOs)...
The Federal Trade Commission’s enforcement action against Caremark Rx, LLC, Zinc Health Services, LLC, and related entities—which centers on how pharmacy benefit managers (PBMs) and their affiliated group purchasing organizations (GPOs)...
NEW YORK — In a major step toward resolving one of the most consequential public health lawsuits in U.S. history, US Bankruptcy Judge Sean Lane has approved Purdue Pharma’s bankruptcy plan, finalizing a $7.4 billion settlement between the...
NEW YORK — In a major step toward resolving one of the most consequential public health lawsuits in U.S. history, US Bankruptcy Judge Sean Lane has approved Purdue Pharma’s bankruptcy plan, finalizing a $7.4 billion settlement between the...
